Angiotensin II acetate

Angiotensin II human acetate is a synthetic form of the naturally occurring human peptide hormone angiotensin II, presented as its acetate salt. It is mainly used in clinical and research settings to study cardiovascular physiology and as a therapeutic agent in certain types of shock. ANGIOTENSIN II ACETATE is a Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications. It is grouped under the following drug class(es): Hormones, Peptides and Vasoconstrictors. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Angiotensin II human acetate, Giapreza and Angiotensin ii triacetate. Its PubChem CID is 172197.

CAS No 68521-88-0
Molecular Formula C52H75N13O14
Molecular Weight 1106.2 g/mol
Synonyms acetic acid;(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid

Frequently Asked Questions